Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer

Clinical trial NCT01664923 · COMPLETED

Trial details

NCT number: NCT01664923
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2012-08-01
Primary completion: 2015-02-01
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.